A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer.
Kondo R, Watanabe S, Shoji S, Ichikawa K, Abe T, Baba J, Tanaka J, Tsukada H, Terada M, Sato K, Maruyama Y, Makino M, Hirata A, Tanaka H, Koya T, Yoshizawa H, Kikuchi T.
Kondo R, et al. Among authors: yoshizawa h.
Oncology. 2018;94(4):223-232. doi: 10.1159/000486622. Epub 2018 Feb 14.
Oncology. 2018.
PMID: 29444512
Clinical Trial.